Bart K J, Lin K F
National Vaccine Program, Department of Health and Human Services, Rockville, Maryland.
Pediatr Clin North Am. 1990 Jun;37(3):735-56. doi: 10.1016/s0031-3955(16)36913-9.
Vaccines have given health care providers control over a substantial portion of the morbidity and mortality in the developing world. Global efforts have immunized two-thirds of the world's children with DTP and polio vaccines; 72% have received BCG and 59% measles vaccine; but only 29% of pregnant women have received two doses of tetanus toxoid. In addition, vaccines against yellow fever, Japanese encephalitis, hepatitis B, rubella, and mumps and meningococcal polysaccharide vaccine are being used in specific regions of the world. New vaccine candidates will enhance the vaccine armamentarium over the next decade to include the causes of pneumonia, diarrhea, and meningitis: Haemophilus influenzae type b, pneumococcal and meningococcal protein conjugate vaccines, typhoid and rotavirus vaccine. Genetically engineered vaccine vehicles, genetic reassortants, and genetic deletions are being investigated as new vaccine candidates.
疫苗已使医疗保健人员能够控制发展中国家很大一部分的发病率和死亡率。全球努力已为世界上三分之二的儿童接种了白喉、破伤风、百日咳和脊髓灰质炎疫苗;72%的儿童接种了卡介苗,59%的儿童接种了麻疹疫苗;但只有29%的孕妇接种了两剂破伤风类毒素。此外,黄热病、日本脑炎、乙型肝炎、风疹、腮腺炎疫苗以及脑膜炎球菌多糖疫苗正在世界特定地区使用。未来十年,新的候选疫苗将扩充疫苗库,纳入引发肺炎、腹泻和脑膜炎的病原体疫苗:b型流感嗜血杆菌疫苗、肺炎球菌和脑膜炎球菌蛋白结合疫苗、伤寒和轮状病毒疫苗。基因工程疫苗载体、基因重配体和基因缺失疫苗正作为新的候选疫苗进行研究。